← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CUPR logoCuprina Holdings (Cayman) Limited Class A Ordinary Shares(CUPR)Earnings, Financials & Key Ratios

CUPR•NASDAQ
$0.26
$4M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutCuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.Show more
  • Revenue$48K-52.0%
  • EBITDA-$2M-55.1%
  • Net Income-$2M-39.4%
  • EPS (Diluted)-0.07-39.2%
  • Gross Margin-6.26%-117.2%
  • EBITDA Margin-3317.55%-223.6%
  • Operating Margin-3404.85%-221.2%
  • Net Margin-3229.52%-190.7%
  • Interest Coverage-44.22-134.2%
Technical→

CUPR Key Insights

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 5 (bottom 5%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CUPR Price & Volume

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock price & volume — 10-year historical chart

Loading chart...

CUPR Growth Metrics

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-6.18%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years-
5 Years-
3 Years-
Last Year-

CUPR Peer Comparison

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HROW logoHROWHarrow Health, Inc.Direct Competitor1.5B40.27-287.6436.41%-1.89%-10.07%4.84
PAHC logoPAHCPhibro Animal Health CorporationDirect Competitor2.38B58.6449.2827.37%6.29%30.81%2.67
ELAN logoELANElanco Animal Health IncorporatedProduct Competitor13.06B26.16-55.666.22%-4.95%-3.64%0.61
ZTS logoZTSZoetis Inc.Product Competitor46.95B111.2218.482.28%28.23%58.23%2.85
PCRX logoPCRXPacira BioSciences, Inc.Product Competitor931.85M23.69148.063.63%1.27%1.31%0.66
PRGO logoPRGOPerrigo Company plcProduct Competitor1.69B12.26-1.19-2.75%-43.5%-50.65%1.35
IDXX logoIDXXIDEXX Laboratories, Inc.Supply Chain46.12B579.2344.2810.42%24.63%70.87%0.67
CHWY logoCHWYChewy, Inc.Supply Chain10.19B24.5927.026.4%1.22%38.76%1.92

Compare CUPR vs Peers

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HROW

Most directly comparable listed peer for CUPR.

Scale Benchmark

vs ZTS

Larger-name benchmark to compare CUPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs HROW, PAHC, ELAN, ZTS

CUPR Income Statement

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue58.5K56.6K100.77K48.32K-
Revenue Growth %--3.26%78.05%-52.05%-
Cost of Goods Sold35.45K36.62K64.17K51.34K-
COGS % of Revenue60.59%64.7%63.68%106.26%-
Gross Profit
23.06K▲ 0%
19.98K▼ 13.4%
36.6K▲ 83.2%
-3.02K▼ 108.3%
-▲ 0%
Gross Margin %39.41%35.3%36.32%-6.26%-
Gross Profit Growth %--13.35%83.23%-108.26%-
Operating Expenses575.81K1.2M1.1M1.64M-
OpEx % of Revenue984.22%2112.7%1096.46%3398.59%-
Selling, General & Admin248.19K830.36K833.45K1.27M-
SG&A % of Revenue424.23%1467.08%827.05%2626.72%-
Research & Development279.79K292.88K167.73K241.36K-
R&D % of Revenue478.23%517.46%166.45%499.5%-
Other Operating Expenses47.83K72.53K103.75K131.62K-
Operating Income
-552.75K▲ 0%
-1.18M▼ 112.7%
-1.07M▲ 9.1%
-1.65M▼ 54.0%
-▲ 0%
Operating Margin %-944.81%-2077.4%-1060.13%-3404.85%-
Operating Income Growth %--112.72%9.14%-54%-
EBITDA-525.29K-1.15M-1.03M-1.6M-
EBITDA Margin %-897.88%-2026.01%-1025.34%-3317.55%-
EBITDA Growth %--118.3%9.89%-55.15%-
D&A (Non-Cash Add-back)27.46K29.09K35.06K42.19K-
EBIT-516.9K-1.09M-1.03M-1.47M-
Net Interest Income-2.78K-2.02K-56.59K-37.21K-
Interest Income0000-
Interest Expense2.78K2.02K56.59K37.21K-
Other Income/Expense33.07K88.62K-17.44K136.66K-
Pretax Income
-519.69K▲ 0%
-1.09M▼ 109.2%
-1.09M▲ 0.1%
-1.51M▼ 38.9%
-▲ 0%
Pretax Margin %-888.29%-1920.83%-1077.44%-3122.05%-
Income Tax07.34K33.79K51.93K-
Effective Tax Rate %0%-0.68%-3.11%-3.44%-
Net Income
-519.69K▲ 0%
-1.09M▼ 110.6%
-1.12M▼ 2.3%
-1.56M▼ 39.4%
-▲ 0%
Net Margin %-888.29%-1933.81%-1110.97%-3229.52%-
Net Income Growth %--110.61%-2.29%-39.39%-
Net Income (Continuing)-519.69K-1.09M-1.12M-1.56M-
Discontinued Operations0000-
Minority Interest0000-
EPS (Diluted)
-0.03▲ 0%
-0.05▼ 110.2%
-0.05▲ 3.6%
-0.07▼ 39.2%
-▲ 0%
EPS Growth %--110.24%3.56%-39.22%-
EPS (Basic)-0.03-0.05-0.05-0.07-
Diluted Shares Outstanding20.5M20.5M21.75M21.75M21.75M
Basic Shares Outstanding20.5M20.5M21.75M21.75M21.75M
Dividend Payout Ratio-----

CUPR Balance Sheet

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'21Dec'22Dec'23Dec'24TTM
Total Current Assets808.19K1.27M1.44M1.66M-
Cash & Short-Term Investments767.29K564.58K35.26K116.47K116.47K
Cash Only767.29K564.58K35.26K116.47K116.47K
Short-Term Investments0000-
Accounts Receivable19.52K440.04K211.88K119.47K-
Days Sales Outstanding121.82.84K767.45902.47-
Inventory06.5K7.67K1.73K-
Days Inventory Outstanding-64.843.612.3-
Other Current Assets14.49K157.9K1.04M1.27M-
Total Non-Current Assets144.86K166.97K150.65K89K-
Property, Plant & Equipment144.86K159.08K150.65K89K-
Fixed Asset Turnover0.40x0.36x0.67x0.54x-
Goodwill0000-
Intangible Assets0000-
Long-Term Investments07.89K00-
Other Non-Current Assets0000-
Total Assets
953.05K▲ 0%
1.44M▲ 50.7%
1.59M▲ 10.4%
1.75M▲ 10.0%
1.75M▲ 0%
Asset Turnover0.06x0.04x0.06x0.03x-
Asset Growth %-50.69%10.42%10.05%-
Total Current Liabilities1.51M3.09M4.43M6.04M-
Accounts Payable220000-
Days Payables Outstanding2.27----
Short-Term Debt19.46K19.95K20.85K55.25K-
Deferred Revenue (Current)0000-
Other Current Liabilities0000-
Current Ratio0.54x0.41x0.32x0.27x0.27x
Quick Ratio0.54x0.41x0.32x0.27x0.27x
Cash Conversion Cycle-----
Total Non-Current Liabilities127.28K122.91K57.51K163.73K-
Long-Term Debt63.12K43.17K21.7K163.73K-
Capital Lease Obligations64.15K79.74K35.81K0-
Deferred Tax Liabilities0000-
Other Non-Current Liabilities0000-
Total Liabilities1.64M3.21M4.48M6.2M-
Total Debt170.03K183.63K121.82K254.79K254.79K
Net Debt-597.26K-380.94K86.56K138.32K138.32K
Debt / Equity-----0.06x
Debt / EBITDA-----
Net Debt / EBITDA-----
Interest Coverage-198.62x-582.94x-18.88x-44.22x-
Total Equity
-683.52K▲ 0%
-1.78M▼ 160.2%
-2.9M▼ 62.9%
-4.46M▼ 53.9%
-4.46M▲ 0%
Equity Growth %--160.17%-62.92%-53.93%-
Book Value per Share-0.03-0.09-0.13-0.21-0.21
Total Shareholders' Equity-683.52K-1.78M-2.9M-4.46M-4.46M
Common Stock24.2K24.2K24.2K24.2K-
Retained Earnings-786.45K-1.88M-3M-4.56M-
Treasury Stock0000-
Accumulated OCI0-261309-1.59K-
Minority Interest0000-

CUPR Cash Flow Statement

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) cash flow — operating, investing & free cash flow history

Line itemDec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-221.86K-1.85M-1.54M-1.24M-1.24M
Operating CF Margin %-379.22%-3268.03%-1530.94%-2557.85%-
Operating CF Growth %--733.71%16.59%19.89%-
Net Income-519.69K-1.09M-1.12M-1.56M-
Depreciation & Amortization27.46K29.09K35.06K42.19K-
Stock-Based Compensation0000-
Deferred Taxes0000-
Other Non-Cash Items4.58K22.98K64.79K54.01K-
Working Capital Changes265.79K-807.22K-523.07K228.36K-
Change in Receivables-18.8K-38.25K-35.02K24.43K-
Change in Inventory0-6.5K-1.16K0-
Change in Payables-2.03K-22000-
Cash from Investing-2.86K-31.28K-67.98K-21.88K-
Capital Expenditures-2.86K-16.05K-67.98K-21.88K-
CapEx % of Revenue4.89%28.36%67.46%45.29%-
Acquisitions0-15.23K00-
Investments-----
Other Investing0000-
Cash from Financing991.39K1.68M1.08M1.34M-
Debt Issued (Net)82.58K-19.46K-20.57K176.43K-
Equity Issued (Net)0000-
Dividends Paid0000-
Share Repurchases0000-
Other Financing908.81K1.7M1.1M1.16M-
Net Change in Cash
766.67K▲ 0%
-202.72K▼ 126.4%
-529.31K▼ 161.1%
81.21K▲ 115.3%
-▲ 0%
Free Cash Flow
-224.72K▲ 0%
-1.87M▼ 730.2%
-1.61M▲ 13.7%
-1.26M▲ 21.9%
-▲ 0%
FCF Margin %-384.11%-3296.39%-1598.4%-2603.14%-
FCF Growth %--730.24%13.67%21.91%-
FCF per Share-0.01-0.09-0.07-0.06-0.06
FCF Conversion (FCF/Net Income)0.43x1.69x1.38x0.79x-
Interest Paid2.78K2.02K727221-
Taxes Paid0000-

CUPR Key Ratios

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202220232024TTM
Gross Margin35.3%36.32%-6.26%-
Net Margin-1933.81%-1110.97%-3229.52%-
Debt / Equity----0.06x
Interest Coverage-582.94x-18.88x-44.22x-
FCF Conversion1.69x1.38x0.79x-
Revenue Growth-3.26%78.05%-52.05%-

CUPR Frequently Asked Questions

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) reported $0.0M in revenue for fiscal year 2024. This represents a 17% decrease from $0.1M in 2021.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) saw revenue decline by 52.0% over the past year.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) reported a net loss of $1.6M for fiscal year 2024.

Dividend & Returns

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) had negative free cash flow of $1.3M in fiscal year 2024, likely due to heavy capital investments.

Explore More CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.